Globus Medical GMED
$66.89 −$1.71 (-2.49%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $66.89 0.00%
Open$68.44
Prev close$68.60
Day range$66.63 – $69.54
Volume1.51M
Market cap$8.86B
P/E (TTM)16.5
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$763.72M-0.7% YoY
Operating profit$178.23M+32.0% YoY
Net profit$141.17M+18.7% YoY
Diluted EPS$1.04+18.2% YoY
Free cash flow$224.84M+5.1% YoY
Operating cash flow$265.23M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin69.1%
Operating margin22.8%
Net margin17.8%
Return on equity12.1%
Return on assets10.5%
Return on invested capital11.8%
Current ratio4.30
Liabilities / assets13.2%
Cash & investments$517.44M
Total debt$93.38M
Net cash (debt)$424.06M
Free cash flow / sales24.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $763.72M | $789.61M | $759.85M | $2.94B | $826.42M |
| Total Operating Revenue | $763.72M | $789.61M | $759.85M | $2.94B | $826.42M |
| Cost of Revenue | $232.92M | $241.44M | $234.07M | $957.80M | $261.11M |
| Gross Profit | $530.80M | $548.17M | $525.79M | $1.98B | $565.31M |
| Operating Expense | $352.57M | $352.70M | $363.81M | $1.44B | $384.00M |
| Selling and Admin Expenses | $288.47M | $286.82M | $297.78M | $1.18B | $318.48M |
| Research & Development | $34.53M | $36.32M | $36.51M | $147.25M | $36.16M |
| Depreciation & Amortization & Depletion | $29.57M | $29.56M | $29.53M | $118.19M | $29.36M |
| -Depreciation & Amortization | $29.57M | $29.56M | $29.53M | $118.19M | $29.36M |
| Operating Profit | $178.23M | $195.47M | $161.98M | $537.19M | $181.31M |
| Net Non-Operating Interest Income (Expense) | $8.41M | $7.07M | $5.43M | $7.14M | $3.31M |
| Total Other Finance Costs | -$8.41M | -$7.07M | -$5.43M | -$7.14M | -$3.31M |
| Other Income (Expense) | -$3.37M | -$12.73M | -$10.34M | $60.74M | -$15.39M |
| Gain on Sale of Security | -$1.71M | -$860,000.00 | -$2.11M | -$3.01M | -$7.15M |
| Special Income (Charges) | -$677,000.00 | -$13.04M | -$10.47M | $60.33M | -$8.63M |
| -Less:Restructuring and Mergern & Acquisition | $677,000.00 | $13.04M | $10.47M | -$60.33M | $8.63M |
| Other Non-Operating Income (Expenses) | -$982,000.00 | $1.17M | $2.25M | $3.41M | $391,000.00 |
| Pretax Profit | $183.27M | $189.82M | $157.07M | $605.07M | $169.23M |
| Tax | $42.10M | $38.25M | $32.77M | $67.20M | $28.64M |
| Net Profit | $141.17M | $151.57M | $124.30M | $537.87M | $140.59M |
| Profit from Continuing Operations | $141.17M | $151.57M | $124.30M | $537.87M | $140.59M |
| Net Income to Parent Company | $141.17M | $151.57M | $124.30M | $537.87M | $140.59M |
| Net Income to Common Stockholders | $141.17M | $151.57M | $124.30M | $537.87M | $140.59M |
| Basic EPS | $1.05 | $1.12 | $0.92 | $3.98 | $1.05 |
| Diluted EPS | $1.04 | $1.10 | $0.90 | $3.92 | $1.03 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $5.53B | $5.49B | $5.44B | $5.30B | $5.30B |
| Total Current Assets | $2.18B | $2.22B | $2.20B | $2.13B | $2.13B |
| Cash and Cash Equivalents & Short-Term Investments | $517.44M | $595.14M | $629.85M | $557.24M | $557.24M |
| -Cash and Cash Equivalents | $441.27M | $507.75M | $560.95M | $526.16M | $526.16M |
| -Short Term Investments | $76.16M | $87.40M | $68.90M | $31.09M | $31.09M |
| Receivables | $723.95M | $739.28M | $735.44M | $743.67M | $743.67M |
| -Accounts Receivable | $675.30M | $692.18M | $686.43M | $678.94M | $678.94M |
| -Taxes Receivable | $48.65M | $47.10M | $49.01M | $64.73M | $64.73M |
| Inventory | $824.14M | $810.90M | $772.60M | $759.28M | $759.28M |
| Other Current Assets | $116.44M | $70.20M | $60.23M | $65.43M | $65.43M |
| Total Non-Current Assets | $3.35B | $3.27B | $3.24B | $3.18B | $3.18B |
| Net PPE | $589.53M | $592.68M | $618.65M | $628.24M | $628.24M |
| -Gross PPE | $1.40B | $1.36B | $1.37B | $1.33B | $1.33B |
| -Accumulated Depreciation | -$808.87M | -$770.09M | -$747.58M | -$705.00M | -$705.00M |
| Investments and Advances | $353.74M | $245.36M | $169.44M | $71.82M | $71.82M |
| -Available for Sale Securities | $175.08M | $140.82M | $89.44M | $34.96M | $34.96M |
| -Held to Maturity Securities | $178.66M | $104.54M | $80.00M | $36.86M | $36.86M |
| Goodwill and Other Intangible Assets | $2.12B | $2.13B | $2.16B | $2.18B | $2.18B |
| -Goodwill | $1.45B | $1.44B | $1.44B | $1.44B | $1.44B |
| -Other Intangible Assets | $667.47M | $692.62M | $720.85M | $745.06M | $745.06M |
| Non-Current Deferred Assets | $205.94M | $224.63M | $214.81M | $218.22M | $218.22M |
| Other Non-Current Assets | $75.99M | $79.24M | $78.96M | $78.78M | $78.78M |
| Total Liabilities | $731.94M | $719.66M | $707.24M | $729.51M | $729.51M |
| Total Current Liabilities | $507.94M | $479.35M | $482.46M | $498.50M | $498.50M |
| Payables | $140.39M | $141.84M | $135.83M | $132.25M | $132.25M |
| -Accounts Payable | $107.43M | $106.94M | $103.66M | $98.85M | $98.85M |
| -Total Tax Payable | $32.97M | $34.90M | $32.17M | $33.40M | $33.40M |
| Current Accrued Expenses | $142.80M | $133.63M | $137.99M | $137.24M | $137.24M |
| Short-Term Debt and Capital Lease Obligation | $14.18M | $14.39M | $15.12M | $14.74M | $14.74M |
| -Current Capital Lease Obligation | $14.18M | $14.39M | $15.12M | $14.74M | $14.74M |
| Current Deferred Liabilities | $27.81M | $27.98M | $26.35M | $27.66M | $27.66M |
| Other Current Liabilities | $25.82M | $23.28M | $20.87M | $19.51M | $19.51M |
| Total Non-Current Liabilities | $224.01M | $240.31M | $224.78M | $231.01M | $231.01M |
| Long Term Debt and Capital Lease Obligation | $93.38M | $96.81M | $100.10M | $103.92M | $103.92M |
| -Long Term Capital Lease Obligation | $93.38M | $96.81M | $100.10M | $103.92M | $103.92M |
| Non-Current Deferred Liabilities | $31.60M | $42.34M | $24.66M | $23.76M | $23.76M |
| Other Non-Current Liabilities | $99.02M | $101.16M | $100.02M | $103.34M | $103.34M |
| Total Equity | $4.80B | $4.77B | $4.73B | $4.57B | $4.57B |
| Stockholders' Equity | $4.80B | $4.77B | $4.73B | $4.57B | $4.57B |
| Capital Stock | $132,000.00 | $134,000.00 | $135,000.00 | $135,000.00 | $135,000.00 |
| -Common Stock | $132,000.00 | $134,000.00 | $135,000.00 | $135,000.00 | $135,000.00 |
| Additional Paid-In Capital | $3.26B | $3.23B | $3.21B | $3.17B | $3.17B |
| Retained Earnings | $1.53B | $1.53B | $1.51B | $1.39B | $1.39B |
| Gains/Losses Not Affecting Retained Earnings | $11.34M | $11.20M | $14.40M | $15.35M | $15.35M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $265.23M | $209.74M | $202.36M | $753.45M | $248.59M |
| Net cash flow from continuing operations | $265.23M | $209.74M | $202.36M | $753.45M | $248.59M |
| Net Income from Continuing Operations | $141.17M | $151.57M | $124.30M | $537.87M | $140.59M |
| Gain/Loss from Continuing Operations | $1.27M | $3.23M | $2.55M | -$66,000.00 | $6.12M |
| Depreciation & Depletion & Amortization | $70.38M | $69.50M | $69.86M | $276.84M | $69.49M |
| Deferred Tax | $9.03M | $7.79M | $7.96M | $18.63M | $18.10M |
| Other Non-Cash Items | -$197,000.00 | $9.38M | $2.96M | -$95.15M | $13.34M |
| Change in Working Capital | $23.41M | -$55.07M | -$28.12M | -$66.80M | -$21.51M |
| -Change in Receivables | $14.87M | -$13.81M | -$13.40M | -$52.18M | -$64.15M |
| -Change in Inventory | -$15.54M | -$27.90M | -$16.65M | -$17.60M | -$178,000.00 |
| -Change in Prepaid Assets | $4.29M | -$7.40M | $6.94M | $11.13M | $17.82M |
| -Change in Payables and Accrued Expense | $21.64M | -$10.76M | -$19.59M | $42.70M | $17.92M |
| -Change In Other Working Capital | -$1.85M | $4.81M | $14.58M | -$50.85M | $7.09M |
| Net cash flow from investing | -$155.90M | -$129.05M | -$182.67M | -$355.01M | -$111.45M |
| Net Cash Flow from Continuing Investing Activities | -$155.90M | -$129.05M | -$182.67M | -$355.01M | -$111.45M |
| Net PPE Purchase and Sale | -$40.39M | -$33.17M | -$39.62M | -$164.68M | -$46.20M |
| Net Business Purchase and Sale | -$16.01M | -$1.50M | -$4.91M | -$252.55M | $9.67M |
| Net Investment Purchase and Sale | -$99.51M | -$94.38M | -$138.15M | $71.96M | -$65.17M |
| Financing Cash Flow | -$130.76M | -$134.50M | $18.20M | -$679.16M | $13.22M |
| Net Cash Flow from Continuing Financing Activities | -$130.76M | -$134.50M | $18.20M | -$679.16M | $13.22M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $0.00 | -$449.99M | $0.00 |
| Net Common Stock Issuance | -$142.94M | -$136.06M | $0.00 | -$300.45M | -$45.00M |
| Proceeds from Stock Option Exercised | $15.88M | $10.97M | $25.96M | $89.76M | $62.76M |
| Net Other Financing Charges | -$3.70M | -$9.41M | -$7.76M | -$18.48M | -$4.54M |
| Ending Cash Balance | $487.69M | $507.75M | $560.95M | $526.16M | $526.16M |
| Net Change in Cash | -$21.44M | -$53.80M | $37.89M | -$280.73M | $150.35M |
| Beginning Cash Balance | $507.75M | $560.95M | $526.16M | $784.44M | $371.77M |
| Effect of Exchange Rate Changes | $1.38M | $598,000.00 | -$3.09M | $22.45M | $4.03M |
| Free Cash Flow | $224.84M | $176.57M | $162.75M | $579.02M | $192.64M |
| Net Intangibles Purchase and Sale | – | – | – | -$9.75M | -$80,000.00 |
No comments yet — be the first to weigh in on GMED.
Sign in to join the discussion.